about
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastasesComparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancerMALDI profiling of human lung cancer subtypes.Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.Gene profiling in breast cancer: time to move forward.The present and future of gene profiling in breast cancer.Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches.Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications.Functional proteomics outlines the complexity of breast cancer molecular subtypes.microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples.Urothelial cancer proteomics provides both prognostic and functional information.DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognosesMelanoma proteomics suggests functional differences related to mutational statusProteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancerPathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenesGenetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationmiRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinomaComputational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patientsIsotopologue Multipoint Calibration for Proteomics Biomarker Quantification in Clinical PracticeBiological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
P50
Q26750508-A7B06B00-F48B-4932-8FA1-34E8A0DA1344Q33472698-42486898-121A-4DD6-8766-7A896B56EC58Q33515026-C9B2675C-A9E9-46A6-90EA-83C5445F8C57Q33778306-133770F5-3147-4BD2-B527-FC5ADC25CE96Q34373936-464F5E74-8915-4142-B16A-6EED72F0D85DQ37833333-7AFFE8B2-8C0E-4048-95EB-D246947D8404Q37962377-1359AE0C-392E-4940-8967-E8851C157C17Q38410125-5D831784-6BB0-46C3-BD20-3E486491F080Q38415968-330248DB-8CD9-4237-A432-70FA0A2E18DEQ41059996-9D137966-AC86-4A67-BAF8-EF80DCE6517FQ41564586-AFC0C193-E137-4ECB-B068-14EE295F6AC1Q46132146-A4DF791F-B837-4F10-A6D1-07A9E452A144Q47156880-B9049ABF-F77B-4339-9DA1-B60E9B86D31AQ53259152-0C9973D0-33CE-42EF-9AEF-880DB69E4D23Q55357247-BA907CBB-BA8A-4072-9858-0B0CCF7180E1Q61798221-388ECC42-9407-412A-A026-1CBD2EBDB0C9Q64059069-AD82AD16-C93A-49F2-8FFB-8628C370DC05Q64235134-C5FF1391-48EC-41CB-BBE0-BC1CC71BC20BQ79829091-676A1BBC-06F8-4BD1-A409-2DDA61572249Q89925950-67EE6A07-C415-4A49-BC31-5B37B0CF5BDDQ89935823-AE180EBA-F273-4E2F-8032-1524C3B5F2A4Q90452666-BE32A472-31B5-4A5A-B30D-FC3B6FD80169Q92434832-44092AE3-DCAC-4865-8A58-D9BC96269B90Q93111695-5F21B16F-3001-4659-9B7D-72AB5C3B60AC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Angelo Gamez-Pozo
@ast
Angelo Gamez-Pozo
@en
Angelo Gamez-Pozo
@es
Angelo Gamez-Pozo
@fr
Angelo Gamez-Pozo
@nl
Angelo Gamez-Pozo
@sl
type
label
Angelo Gamez-Pozo
@ast
Angelo Gamez-Pozo
@en
Angelo Gamez-Pozo
@es
Angelo Gamez-Pozo
@fr
Angelo Gamez-Pozo
@nl
Angelo Gamez-Pozo
@sl
altLabel
Angelo Gámez
@en
prefLabel
Angelo Gamez-Pozo
@ast
Angelo Gamez-Pozo
@en
Angelo Gamez-Pozo
@es
Angelo Gamez-Pozo
@fr
Angelo Gamez-Pozo
@nl
Angelo Gamez-Pozo
@sl
P1053
N-2506-2014
P106
P21
P31
P3829
P496
0000-0002-8931-0624